Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Trinity Biotech PLC as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +6 vs. Q3 2023
- Shares held
- 6.02M
- −118.5K (−1.9%) vs. Q3 2023
- Total value
- $2.58M
- −$1.91M (−42.5%) vs. Q3 2023
- New holders
- 7
- 0 more added
- Sold out
- 1
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $379.5K |
| Q1 2026 | 23 | $588.9K |
| Q4 2025 | 27 | $673.3K |
| Q3 2025 | 28 | $2.81M |
| Q2 2025 | 25 | $1.66M |
| Q1 2025 | 27 | $468.1K |
| Q4 2024 | 23 | $2.30M |
| Q3 2024 | 19 | $2.95M |
| Q2 2024 | 20 | $5.67M |
| Q1 2024 | 19 | $5.95M |
| Q4 2023 | 26 | $2.58M |
| Q3 2023 | 20 | $4.49M |
| Q2 2023 | 20 | $5.93M |
| Q1 2023 | 20 | $5.96M |
| Q4 2022 | 20 | $6.51M |
| Q3 2022 | 21 | $7.50M |
| Q2 2022 | 20 | $8.92M |
| Q1 2022 | 22 | $9.56M |
| Q4 2021 | 21 | $7.70M |
| Q3 2021 | 23 | $11.9M |
| Q2 2021 | 29 | $16.6M |
| Q1 2021 | 34 | $20.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Trinity Biotech PLC; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 488 | $0 | 0.00% | +488 | New |
| Citigroup Inc | 4 | $2 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17 | $7 | 0.00% | −125−88.0% | Reduced |
| Atwood & Palmer Inc | 100 | $43 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 972 | $417 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,204 | $516 | 0.00% | 00.0% | Unchanged |
| CGC Financial Services, LLC | 1,500 | $644 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 1,860 | $797 | 0.00% | 00.0% | Unchanged |
| Williams & Novak, LLC | 10,000 | $4.29K | 0.00% | +10,000 | New |
| Dynamic Advisor Solutions LLC | 10,000 | $5.30K | 0.00% | 00.0% | Unchanged |
| Redwood Wealth Management Group, LLC | 14,150 | $6.07K | 0.01% | −2,500−15.0% | Reduced |
| Morgan Stanley | 14,552 | $6.24K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 15,466 | $6.63K | 0.00% | +15,466 | New |
| Two Sigma Securities, LLC | 19,037 | $8.17K | 0.00% | +19,037 | New |
| CI Private Wealth, LLC | 22,035 | $9.45K | 0.00% | +22,035 | New |
| State of New Jersey Common Pension Fund D | 27,062 | $11.6K | 0.00% | 00.0% | Unchanged |
| Aristides Capital LLC | 28,057 | $12.0K | 0.01% | −134,260−82.7% | Reduced |
| Wealthsource Partners, LLC | 30,200 | $13.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 32,513 | $13.9K | 0.00% | +32,513 | New |
| Becker Capital Management Inc | 90,000 | $38.6K | 0.00% | +90,000 | New |
| Cambridge Investment Research Advisors, Inc. | 111,400 | $48.0K | 0.00% | 00.0% | Unchanged |
| Whitefort Capital Management, LP | 409,517 | $175.7K | 0.11% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 684,882 | $292.0K | 0.00% | −38,654−5.3% | Reduced |
| Renaissance Technologies LLC | 1,353,898 | $581.0K | 0.00% | −9,300−0.7% | Reduced |
| Stonehill Capital Management LLC | 1,512,975 | $649.0K | 1.28% | 00.0% | Unchanged |
| Hunter Associates Investment Management LLC | 1,625,900 | $700.0K | 0.13% | −106,495−6.1% | Reduced |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −16,691−100.0% | Sold out |